A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

Clinical trial NCT06702449 · RECRUITING

Trial details

NCT number: NCT06702449
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Urinary Tract Infections

Start date: 2024-11-19
Primary completion: 2027-05-31
Enrollment: 448

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.